Performance of a screening-trained DL model for pulmonary nodule malignancy estimation of incidental clinical nodules - Quiz - MDSpire

Performance of a screening-trained DL model for pulmonary nodule malignancy estimation of incidental clinical nodules

  • By

  • Renate Dinnessen

  • Dré Peeters

  • Noa Antonissen

  • Firdaus A. A. Mohamed Hoesein

  • Hester A. Gietema

  • Ernst Th. Scholten

  • Cornelia Schaefer-Prokop

  • Colin Jacobs

  • July 15, 2025

  • 0 min

Share

Original Source(s)

Performance of a screening-trained DL model for pulmonary nodule malignancy estimation of incidental clinical nodules

  • by Renate Dinnessen, Dré Peeters, Noa Antonissen, Firdaus A. A. Mohamed Hoesein, Hester A. Gietema, Ernst Th. Scholten, Cornelia Schaefer-Prokop, Colin Jacobs

  • July 15, 2025

Related Content

FDA Cleared ≠ FDA Validated

Most AI medical devices reach the market without independent evidence of safety or effectiveness.

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size

Assessment of bone density and microarchitecture in patients with familial partial lipodystrophy